Table of Contents
<< Previous Issue | Sept 2017 (Vol: 2017, Issue: 9) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Merck & Co. Acquires German Start-Up Rigontec with Aim of Advancing Immuno-Oncology Success
-
Rocket Pharmaceuticals Reverse Merges with Inotek Pharmaceuticals to Advance Gene Therapies
- Section: Research & Development
-
Lilly Pays Nektar US$150 M Upfront to Co-Develop Broad Immunological Therapy
-
AstraZeneca and Takeda Partner on Development of Parkinson’s Candidate